Global Lacrimal Duct Stent Tube Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2029 | Says FMI Analyst
Lacrimal device is a protective ophthalmic device that aids in keeping eye moist as well as free of dust particles. Lacrimal devices usually are constrained to nasal punctum and lacrimal ducts of the eye. Lacrimal devices such as lacrimal stents and intubation sets, lacrimal plugs, lacrimal cannules significantly plays an important role in treatment and repair of lacrimal drainage system. Among these lacrimal devices, lacrimal stents and intubations sets are exclusively indicated for treatment of epiphora both in infants and adults, stenosis, obstruction, and to treat conditions necessitating dacryocystorhinostomy.
The lacrimal stents registers high demand from ophthalmic clinics due to increasing eye conditions primarily imperforation of nasolacrimal duct. Lacrimal stent is a small silicone tube placed at point of constriction so as to open it up. The lacrimal intubation set comprises of a balloon and catheter made of silicone. Majority of leading players in ophthalmology are focused on manufacturing lacrimal devices that are indicated for stenosis and comprehensive treatment of nasolacrimal duct obstruction. The leading companies in lacrimal devices market are specialized in offering bicanalicular and monocalicular lacrimal stents and tubes.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9649
Lacrimal Devices Market: Drivers and Restraints
The introduction of highly precise and upgraded lacrimal devices such as launch of new lacrimal cannula that combines strength and flexibility to minimize trauma by allowing easy access to canaliculus has registered to be prominent driving factor responsible for revenue generation in global lacrimal devices market. Also, the growing demand for lacrimal devices particularly lacrimal dilators and cannulas from hospitals and optometrist or general physicians performing lacrimal irrigation and dilation is expected to further propel the revenue growth of global lacrimal devices market. Moreover, the ease of lacrimal irrigation and treatment procedures, effective results obtained by using cost-effective lacrimal devices further drives the revenue growth in lacrimal devices market. However, lack of eye experts or physicians to perform ophthalmic surgeries in under-developed regions deters the revenue growth in lacrimal devices market.
Lacrimal Devices Market: Segmentation
The global lacrimal devices market is classified on the basis of device type, end user and region.
Based on device type, lacrimal devices market is segmented into following:
- Lacrimal Cannula
- Curved Lacrimal Cannula
- Straight Lacrimal Cannula
- Pediatric Lacrimal Flush Cannula
- Lacrimal Plugs
- Lacrimal Stents & Tubes
- Monocanalicular Stents
- Bicanalicular Stents
- Lacrimal Dilators
Based on end user, lacrimal devices market is segmented into following:
- Ophthalmic Clinics
- Ambulatory Surgical Centers
Lacrimal Devices Market: Overview
Easy FDA approvals for lacrimal devices has led to high revenues generations due to increased demand from hospitals and ophthalmology clinics. A large number of leading players in lacrimal devices market are focused on engineering improved lacrimal devices with easy usage and low cost devices. Large population base for retinal diseases, and robust awareness among patients about surgical treatments of distinct retinal diseases drives the revenue generation in global lacrimal devices market. The lacrimal stents and tubes followed by lacrimal cannulas are most commonly preferred lacrimal devices, thus registering significant revenue share in global lacrimal devices market. On the basis of end user, ophthalmology clinics followed by hospitals registers significant revenues in global lacrimal devices market due to increase in number of ophthalmic surgeries performed.
Lacrimal Devices Market: Regional Overview
Among the regional presence, North America is expected to be the leading revenue generating region for lacrimal devices owing to increasing target population with retinal diseases across the region. Europe is expected to remain the second largest market for lacrimal devices over the forecast period due to increase in government initiates taken to promote health care. Followed by Europe, East Asia registers to be a third largest revenue contributing market in lacrimal devices market due to better consumer awareness about eye care and improved disease management. Middle East and Africa however is projected to register slow growth in lacrimal devices owing to poor awareness among patient population regarding lacrimal devices.
Lacrimal Devices Market: Key Players
Some of the major lacrimal devices manufacturers present across the globe are B. Braun Melsungen AG, Cook Medical, Inc., Medtronic plc, Stryker corp., Smiths Medical, ConMed Corporation, Aspen Medical Europe Ltd., KATENA PRODUCTS, INC., and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-9649
Regional analysis for Lacrimal Devices Market includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil
- Europe (Germany, Italy, France, U.K, Spain, Poland, Russia)
- East Asia (China, Japan, south Korea)
- South Asia (India, Thailand, Malaysia)
- Oceania (Australia & New Zealand)
- The Middle East & Africa (GCC Countries, S. Africa, Northern Africa)
The report on Lacrimal Devices Market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report on Lacrimal Devices Market provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report on Lacrimal Devices Market also maps the qualitative impact of various market factors on market segments and geographies.
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Centrifugal Blood Pump Market – A slew of cardiovascular products were launched for the management of cardiac disorders over the last decade and development of more are currently underway. With leading manufacturers expecting the demand to surge amid COVID-19, centrifugal blood pump sales are set to grow steadily through 2030.
Pharmaceutical Intermediates Market – The global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030, and the number is rising rapidly. Pharmaceutical drugs have remained key to management of chronic diseases and other diseases.
Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org